Business Context and Reporting Period
Company: U Power Ltd (Foreign Private Issuer)
Filing Type: Form 6-K
Reporting Period: January 2025 (Event date: January 24, 2025; Closing date: January 27, 2025)
Principal Executive Offices: Wuhu City, Anhui Province, People's Republic of China
The filing reports the completion of a Registered Direct Offering and a concurrent private placement of securities to institutional investors.
Key Financial Metrics and Transaction Details
| Metric | Value |
|---|---|
| Gross Proceeds | Approximately $5,000,000 |
| Placement Agent Fee | 7.0% of aggregate gross proceeds |
| Expense Reimbursement Cap | $50,000 |
| Use of Proceeds | Working capital and general corporate purposes |
Securities Issued:
- Class A Ordinary Shares: 648,000 shares at $4.80 per share.
- Pre-Funded Warrants: 393,668 warrants (exercise price $0.0001) at $4.7999 per warrant.
- Common Warrants: 1,562,502 warrants (exercise price $4.80, 5-year term) issued in a concurrent private placement.
Financial Performance: The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.
Material Changes and Transaction Structure
The primary material change is the capital raise via the Registered Direct Offering. Key structural elements include:
- Beneficial Ownership Limitations: Pre-Funded Warrants were utilized to prevent purchasers from exceeding 4.99% (or 9.99% at election) beneficial ownership limits.
- Warrant Amendment: Existing warrants held by an investor were amended to reduce the exercise price to $4.80 per share, effective upon closing.
- Lock-Up Agreements: Directors and executive officers agreed to a 120-day lock-up period on their securities.
- Issuance Restrictions: The Company is prohibited from entering into Variable Rate Transactions for 120 days and from issuing new shares or filing registration statements for 60 days post-closing.
Guidance, Outlook, and Risks
Management Commentary: Management intends to use net proceeds for working capital and general corporate purposes. No specific operational guidance or revenue outlook was provided in this filing.
Risks and Contingencies:
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to inherent uncertainties.
- Resale Restrictions: Common Warrants and underlying shares are unregistered and may not be sold in the U.S. absent registration or an exemption. Cashless exercise is permitted if no effective registration statement exists.
- Ownership Caps: Exercise of Common Warrants is subject to beneficial ownership limitations (4.99% or 9.99%), which may restrict immediate full exercise.
Investor Verification Checklist
- Verify the exact net proceeds after deducting the 7% placement fee and up to $50,000 in expenses.
- Confirm the dilution impact of the 648,000 shares and 1,562,502 common warrants on existing shareholders.
- Review the specific terms of the "Warrant Amendment Agreement" (Exhibit 10.3) to understand the scope of the exercise price reduction for existing investors.
- Check the Company's Form 20-F for the year ended December 31, 2023, for detailed risk factors referenced in the forward-looking statements.
- Monitor the 60-day and 120-day issuance restrictions to assess near-term capital raising flexibility.